Fennec Pharmaceuticals (FENC)

• Market cap: $280M
• 1 day: 3.8%
• 5 days: 5%
• 1 month: -6.51%
• 3 months: -7.67%
• 6 months: 0.86%
• Year to date: 30.21%
• 1 year: 35.15%
• 5 years: 4.73%
• 10 years: -31.75%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32